Background: The international guidelines of the Global Initiative for Asthma (GINA) define the bronchial asthma (AB) as a chronic inflammatory disorder of the airways characterized by bronchial obstruction more or less accessionale, reversible spontaneously or in response to pharmacological therapy. The increasing prevalence of asthma and the costs borne by the patient, as well as the health care system, have led to the development of extensive research on the mechanisms and treatment of this disease. Aim: Increase the awareness that asthma is a global public health problem and introduce critical recommendations about the diagnosis and treatment of asthma. Materials and methods: The guidelines and bibliographic material accessible from PubMed emphasize the importance of finding strategies directed to achieving and maintaining of asthma controlma. Results: Guidelines recommend to develop a care plan organized into four components related to each other: 1) raising awareness of the patient to develop a close relationship with your doctor, 2) dentify and reduce exposure to risk factors, 3) to evaluate, treat and monitor asthma, 4) manage exacerbations of asthma. Pharmacists have an important role in the management of pharmacological therapy within the health care team. They should be more involved in treatment of the asthmatic patient, in the improvement of health care quality and prevent problems related to drugs.
Background: Le linee guida internazionali del Global Initiative for Asthma (GINA) definiscono l’asma bronchiale (AB) come un disordine infiammatorio cronico delle vie aeree, caratterizzato da ostruzione bronchiale più o meno accessionale, reversibile spontaneamente o in seguito a terapia farmacologica. La crescente prevalenza di asma e i costi notevoli a carico del paziente, nonché del sistema sanitario, hanno condotto allo sviluppo di intense attività di ricerca sui meccanismi e sul trattamento di tale patologia. Scopo: Aumentare la consapevolezza che l’asma costituisce un problema di salute pubblica globale e presentare raccomandazioni essenziali per la diagnosi e trattamento dell’asma. Materiali e metodi: Le linee guide e i materiali bibliografici accessibile da PubMed sottolineano l'importanza di trovare delle strategie rivolte al raggiungimento e mantenimento del controllo dell’asma. Risultati: Le linee guida raccomandano di sviluppare un piano di assistenza organizzato in quattro componenti tra loro correlate: 1) sensibilizzare il paziente a sviluppare uno stretto rapporto di collaborazione con il medico, 2) identificare e ridurre l’esposizione ai fattori di rischio, 3) valutare, trattare e monitorare l’asma, 4) gestire una riacutizzazione di asma. I farmacisti hanno un ruolo importante nella gestione della terapia farmacologica all'interno del team di assistenza sanitaria. Dovrebbero essere maggiormente coinvolti nella cura del paziente asmatico, nel miglioramento della qualità di assistenza sanitaria e prevenire i problemi legati ai farmaci.
ASMA BRONCHIALE: DIAGNOSI, TERPIA E IL RUOLO DEL FARMACISTA
EVANGELISTA RAMIREZ, MILAGROS DEISY
2015/2016
Abstract
Background: The international guidelines of the Global Initiative for Asthma (GINA) define the bronchial asthma (AB) as a chronic inflammatory disorder of the airways characterized by bronchial obstruction more or less accessionale, reversible spontaneously or in response to pharmacological therapy. The increasing prevalence of asthma and the costs borne by the patient, as well as the health care system, have led to the development of extensive research on the mechanisms and treatment of this disease. Aim: Increase the awareness that asthma is a global public health problem and introduce critical recommendations about the diagnosis and treatment of asthma. Materials and methods: The guidelines and bibliographic material accessible from PubMed emphasize the importance of finding strategies directed to achieving and maintaining of asthma controlma. Results: Guidelines recommend to develop a care plan organized into four components related to each other: 1) raising awareness of the patient to develop a close relationship with your doctor, 2) dentify and reduce exposure to risk factors, 3) to evaluate, treat and monitor asthma, 4) manage exacerbations of asthma. Pharmacists have an important role in the management of pharmacological therapy within the health care team. They should be more involved in treatment of the asthmatic patient, in the improvement of health care quality and prevent problems related to drugs.È consentito all'utente scaricare e condividere i documenti disponibili a testo pieno in UNITESI UNIPV nel rispetto della licenza Creative Commons del tipo CC BY NC ND.
Per maggiori informazioni e per verifiche sull'eventuale disponibilità del file scrivere a: unitesi@unipv.it.
https://hdl.handle.net/20.500.14239/17735